3 Articles found

Betalin Therapeutics Ltd. articles

Israeli scientists: Cure for insulin-dependent diabetics within five years

A team of Jerusalem-based researchers and entrepreneurs claim they have a cure for diabetesthat could hit the market as early as within the next few years.

Betalin Therapeutics has developed the first bio-artificial pancreas, composed of pig’s lung tissue and insulin secreting cells. The artificial pancreas would be implanted into the patient and connect with his or her blood vessels, and then be able to measure the body&

Oct. 3, 2019

Jerusalem firm in funding bid to test ‘micro-pancreas’ on humans

An implantable ‘micro-pancreas’ with the ability to produce insulin in response to blood glucose levels has been created by Israeli scientists.

Betalin Therapeutics has tested the technology on animals with some success and is now looking to raise enough funds to be able to put it through clinical trials.

It combines cells and a biological scaffo

Dec. 1, 2019

Israeli artificial pancreas may one day cure diabetes

The Engineered Micro Pancreas from Betalin Therapeutics is heading closer to clinical trials in humans.

Ahead of International Diabetes Day, November 14, Israeli startup Betalin Therapeutics announced that it is beginning the application process for clinical trials of its revolutionary artificial pancreas.

Betalin’s Engineered Micro Pancreas (EMP) aims to free patients suffering from the most severe types of dia

Jan. 5, 2020

Betalin Therapeutics Ltd. articles

Israeli scientists: Cure for insulin-dependent diabetics within five years

Jerusalem firm in funding bid to test ‘micro-pancreas’ on humans

Israeli artificial pancreas may one day cure diabetes

Contact supplier